Sagent Pharmaceuticals Announces the Launch of Leucovorin Calcium for Injection
October 29, 2012 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Oct. 29, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Leucovorin Calcium for Injection, a folic acid derivative, and an adjuvant...
Sagent Pharmaceuticals Sets Date and Time for Release of Third Quarter 2012 Financial Results
October 25, 2012 16:49 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that it will release financial results for the third quarter of 2012 pre-market on...
Sagent Pharmaceuticals Announces the Launch of Caffeine Citrate Injection, USP and Caffeine Citrate Oral Solution, USP
October 03, 2012 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Oct. 3, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Caffeine Citrate Injection, USP and Caffeine Citrate Oral Solution, USP,...
Sagent Pharmaceuticals Announces the Launch of Vancomycin Hydrochloride for Injection, USP
September 28, 2012 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Sept. 28, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Vancomycin Hydrochloride for Injection, USP, an anti-infective, in a 5...
Sagent Pharmaceuticals Announces the Launch of Ondansetron Injection, USP
September 10, 2012 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Ondansetron Injection, USP, an antiemetic, in two latex-free vial...
Sagent Pharmaceuticals Announces the Launch of Oxaliplatin for Injection, USP
August 09, 2012 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Oxaliplatin for Injection, USP, the generic form of the chemotherapy drug,...
Sagent Pharmaceuticals Reports Second Quarter 2012 Financial Results
August 09, 2012 07:00 ET
|
Sagent Pharmaceuticals, Inc.
Revenue Growth Driven by Products Launched in the Last Twelve Months
Company Revises Guidance for 2012
SCHAUMBURG, Ill., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc....
Sagent Pharmaceuticals Sets Date and Time for Release of Second Quarter 2012 Financial Results
July 26, 2012 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., July 26, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that it will release financial results for the second quarter of 2012 pre-market on...
Sagent Pharmaceuticals Announces Launch of Oxacillin for Injection, USP
July 24, 2012 16:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., July 24, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Oxacillin for Injection, USP, in three latex-free, preservative-free vial...
Sagent Pharmaceuticals Announces Launch of Atracurium Besylate Injection, USP
May 18, 2012 09:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., May 18, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Atracurium Besylate Injection, USP, the generic form of the neuromuscular...